Analysed OLEMA PHARMACEUTICALS INC (OLMA:NASDAQ) News Sources
Assessing Olema Pharmaceuticals (OLMA) Valuation After Adding Dr. Prakash Raman To The Board
09-05-2026
yahoo.com
ESR1-Mutated Metastatic Breast Cancer Market Expected to Grow Rapidly at 9.6% CAGR During the Forecast Period (2026–2036) Due to the Emergence of Novel Oral SERDs and Targeted Agents | DelveInsight
20-05-2026
yahoo.com
Olema Oncology Announces Encouraging Initial Clinical Data from the Phase 1 Study of OP-3136, a KAT6 Inhibitor, at 2026 ASCO Annual Meeting
21-05-2026
yahoo.com
Olema Oncology Sees Early Hope As Cancer Drug Shows Tumor Shrinkage In Phase 1 Study
22-05-2026
stocktwits.com
Olema Oncology Announces Clinical Trial Collaboration and Supply Agreement with Bayer to Evaluate OP-3136 in Combination with NUBEQA® (darolutamide) in Metastatic Castration-Resistant Prostate Cancer
26-05-2026
yahoo.com
What is the current price of OLEMA PHARMACEUTICALS INC (OLMA:NASDAQ)?
The current price of OLEMA PHARMACEUTICALS INC (OLMA:NASDAQ) is $9.34.
OLEMA PHARMACEUTICALS INC (OLMA:NASDAQ) absolute price change since previous trading day?
The absolute price change of OLEMA PHARMACEUTICALS INC (OLMA:NASDAQ) since the previous trading day is $0.15.
OLEMA PHARMACEUTICALS INC (OLMA:NASDAQ) percentage price change since previous trading day?
The percentage price change of OLEMA PHARMACEUTICALS INC (OLMA:NASDAQ) since the previous trading day is 1.6322%.
What is the most recent average sentiment score for OLEMA PHARMACEUTICALS INC (OLMA:NASDAQ)?
The most recent average sentiment score for OLEMA PHARMACEUTICALS INC (OLMA:NASDAQ) is 86 out of 100.
What is the most recent average sentiment for OLEMA PHARMACEUTICALS INC (OLMA:NASDAQ)?
The most recent sentiment for OLEMA PHARMACEUTICALS INC (OLMA:NASDAQ) is .
SEC-8K** Filing Available For OLEMA PHARMACEUTICALS INC (OLMA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.